【市場調査レポート】神経系マーカーのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Nervous System Markers Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。神経系マーカーのグローバル市場インサイト・予測（～2028年） / Global Nervous System Markers Market Insights, Forecast to 2028 / QY2207E10425資料のイメージです。

• レポートコード：QY2207E10425
• 出版社/出版日：QYResearch / 2022年7月
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Multi User	￥1,087,800 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の神経系マーカーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に神経系マーカーの世界市場のxxx％を占める「イメージングバイオマーカー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「脊髄性筋萎縮症（SMA）」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の神経系マーカーの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの神経系マーカー市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの神経系マーカー市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

神経系マーカーのグローバル主要メーカーには、Athena Diagnostics、Myriad RBM、AbaStar MDx、QIAGEN、Thermo Fisher Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

神経系マーカー市場は、種類と用途によって区分されます。世界の神経系マーカー市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
イメージングバイオマーカー、メタボロミクスバイオマーカー、プロテオミクスバイオマーカー、ゲノミクスバイオマーカー

【用途別セグメント】
脊髄性筋萎縮症（SMA）、多発性硬化症、うつ病、統合失調症、ハンチントン病、パーキンソン病、アルツハイマー病

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 神経系マーカー製品概要
- 種類別市場（イメージングバイオマーカー、メタボロミクスバイオマーカー、プロテオミクスバイオマーカー、ゲノミクスバイオマーカー）
- 用途別市場（脊髄性筋萎縮症（SMA）、多発性硬化症、うつ病、統合失調症、ハンチントン病、パーキンソン病、アルツハイマー病）
- 調査の目的
・エグゼクティブサマリー
- 世界の神経系マーカー販売量予測2017-2028
- 世界の神経系マーカー売上予測2017-2028
- 神経系マーカーの地域別販売量
- 神経系マーカーの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別神経系マーカー販売量
- 主要メーカー別神経系マーカー売上
- 主要メーカー別神経系マーカー価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（イメージングバイオマーカー、メタボロミクスバイオマーカー、プロテオミクスバイオマーカー、ゲノミクスバイオマーカー）
- 神経系マーカーの種類別販売量
- 神経系マーカーの種類別売上
- 神経系マーカーの種類別価格
・用途別市場規模（脊髄性筋萎縮症（SMA）、多発性硬化症、うつ病、統合失調症、ハンチントン病、パーキンソン病、アルツハイマー病）
- 神経系マーカーの用途別販売量
- 神経系マーカーの用途別売上
- 神経系マーカーの用途別価格
・北米市場
- 北米の神経系マーカー市場規模（種類別、用途別）
- 主要国別の神経系マーカー市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの神経系マーカー市場規模（種類別、用途別）
- 主要国別の神経系マーカー市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の神経系マーカー市場規模（種類別、用途別）
- 主要国別の神経系マーカー市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の神経系マーカー市場規模（種類別、用途別）
- 主要国別の神経系マーカー市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの神経系マーカー市場規模（種類別、用途別）
- 主要国別の神経系マーカー市場規模（トルコ、サウジアラビア）
・企業情報
Athena Diagnostics、Myriad RBM、AbaStar MDx、QIAGEN、Thermo Fisher Scientific
・産業チェーン及び販売チャネル分析
- 神経系マーカーの産業チェーン分析
- 神経系マーカーの原材料
- 神経系マーカーの生産プロセス
- 神経系マーカーの販売及びマーケティング
- 神経系マーカーの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 神経系マーカーの産業動向
- 神経系マーカーのマーケットドライバー
- 神経系マーカーの課題
- 神経系マーカーの阻害要因
・主な調査結果

A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathogenic as well as normal biological process in terms of therapeutic intervention. Biomarkers can also be utilized in combination for accessing the state of the disease of an individual.
Market Analysis and Insights: Global Nervous System Markers Market
Due to the COVID-19 pandemic, the global Nervous System Markers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Imaging Biomarkers accounting for % of the Nervous System Markers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Spinal Muscular Atrophy (SMA) segment is altered to an % CAGR throughout this forecast period.
China Nervous System Markers market size is valued at US$ million in 2021, while the US and Europe Nervous System Markers are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nervous System Markers landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Nervous System Markers include Athena Diagnostics, Myriad RBM, AbaStar MDx, QIAGEN and Thermo Fisher Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Nervous System Markers Scope and Segment
Nervous System Markers market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nervous System Markers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Imaging Biomarkers
Metabolomics Biomarkers
Proteomic Biomarkers
Genomics Biomarkers
Segment by Application
Spinal Muscular Atrophy (SMA)
Multiple Sclerosis
Depression
Schizophrenia
Huntington’s Disease
Parkinson’s Disease
Alzheimer’s Disease
By Company
Athena Diagnostics
Myriad RBM
AbaStar MDx
QIAGEN
Thermo Fisher Scientific
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Nervous System Markers Product Introduction
1.2 Market by Type
1.2.1 Global Nervous System Markers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Imaging Biomarkers
1.2.3 Metabolomics Biomarkers
1.2.4 Proteomic Biomarkers
1.2.5 Genomics Biomarkers
1.3 Market by Application
1.3.1 Global Nervous System Markers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Spinal Muscular Atrophy (SMA)
1.3.3 Multiple Sclerosis
1.3.4 Depression
1.3.5 Schizophrenia
1.3.6 Huntington’s Disease
1.3.7 Parkinson’s Disease
1.3.8 Alzheimer’s Disease
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nervous System Markers Sales Estimates and Forecasts 2017-2028
2.2 Global Nervous System Markers Revenue Estimates and Forecasts 2017-2028
2.3 Global Nervous System Markers Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nervous System Markers Sales by Region
2.4.1 Global Nervous System Markers Sales by Region (2017-2022)
2.4.2 Global Sales Nervous System Markers by Region (2023-2028)
2.5 Global Nervous System Markers Revenue by Region
2.5.1 Global Nervous System Markers Revenue by Region (2017-2022)
2.5.2 Global Nervous System Markers Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nervous System Markers Sales by Manufacturers
3.1.1 Global Top Nervous System Markers Manufacturers by Sales (2017-2022)
3.1.2 Global Nervous System Markers Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nervous System Markers in 2021
3.2 Global Nervous System Markers Revenue by Manufacturers
3.2.1 Global Nervous System Markers Revenue by Manufacturers (2017-2022)
3.2.2 Global Nervous System Markers Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nervous System Markers Revenue in 2021
3.3 Global Nervous System Markers Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nervous System Markers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nervous System Markers Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nervous System Markers Sales by Type
4.1.1 Global Nervous System Markers Historical Sales by Type (2017-2022)
4.1.2 Global Nervous System Markers Forecasted Sales by Type (2023-2028)
4.1.3 Global Nervous System Markers Sales Market Share by Type (2017-2028)
4.2 Global Nervous System Markers Revenue by Type
4.2.1 Global Nervous System Markers Historical Revenue by Type (2017-2022)
4.2.2 Global Nervous System Markers Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nervous System Markers Revenue Market Share by Type (2017-2028)
4.3 Global Nervous System Markers Price by Type
4.3.1 Global Nervous System Markers Price by Type (2017-2022)
4.3.2 Global Nervous System Markers Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nervous System Markers Sales by Application
5.1.1 Global Nervous System Markers Historical Sales by Application (2017-2022)
5.1.2 Global Nervous System Markers Forecasted Sales by Application (2023-2028)
5.1.3 Global Nervous System Markers Sales Market Share by Application (2017-2028)
5.2 Global Nervous System Markers Revenue by Application
5.2.1 Global Nervous System Markers Historical Revenue by Application (2017-2022)
5.2.2 Global Nervous System Markers Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nervous System Markers Revenue Market Share by Application (2017-2028)
5.3 Global Nervous System Markers Price by Application
5.3.1 Global Nervous System Markers Price by Application (2017-2022)
5.3.2 Global Nervous System Markers Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nervous System Markers Market Size by Type
6.1.1 North America Nervous System Markers Sales by Type (2017-2028)
6.1.2 North America Nervous System Markers Revenue by Type (2017-2028)
6.2 North America Nervous System Markers Market Size by Application
6.2.1 North America Nervous System Markers Sales by Application (2017-2028)
6.2.2 North America Nervous System Markers Revenue by Application (2017-2028)
6.3 North America Nervous System Markers Market Size by Country
6.3.1 North America Nervous System Markers Sales by Country (2017-2028)
6.3.2 North America Nervous System Markers Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Nervous System Markers Market Size by Type
7.1.1 Europe Nervous System Markers Sales by Type (2017-2028)
7.1.2 Europe Nervous System Markers Revenue by Type (2017-2028)
7.2 Europe Nervous System Markers Market Size by Application
7.2.1 Europe Nervous System Markers Sales by Application (2017-2028)
7.2.2 Europe Nervous System Markers Revenue by Application (2017-2028)
7.3 Europe Nervous System Markers Market Size by Country
7.3.1 Europe Nervous System Markers Sales by Country (2017-2028)
7.3.2 Europe Nervous System Markers Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nervous System Markers Market Size by Type
8.1.1 Asia Pacific Nervous System Markers Sales by Type (2017-2028)
8.1.2 Asia Pacific Nervous System Markers Revenue by Type (2017-2028)
8.2 Asia Pacific Nervous System Markers Market Size by Application
8.2.1 Asia Pacific Nervous System Markers Sales by Application (2017-2028)
8.2.2 Asia Pacific Nervous System Markers Revenue by Application (2017-2028)
8.3 Asia Pacific Nervous System Markers Market Size by Region
8.3.1 Asia Pacific Nervous System Markers Sales by Region (2017-2028)
8.3.2 Asia Pacific Nervous System Markers Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Nervous System Markers Market Size by Type
9.1.1 Latin America Nervous System Markers Sales by Type (2017-2028)
9.1.2 Latin America Nervous System Markers Revenue by Type (2017-2028)
9.2 Latin America Nervous System Markers Market Size by Application
9.2.1 Latin America Nervous System Markers Sales by Application (2017-2028)
9.2.2 Latin America Nervous System Markers Revenue by Application (2017-2028)
9.3 Latin America Nervous System Markers Market Size by Country
9.3.1 Latin America Nervous System Markers Sales by Country (2017-2028)
9.3.2 Latin America Nervous System Markers Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Nervous System Markers Market Size by Type
10.1.1 Middle East and Africa Nervous System Markers Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nervous System Markers Revenue by Type (2017-2028)
10.2 Middle East and Africa Nervous System Markers Market Size by Application
10.2.1 Middle East and Africa Nervous System Markers Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nervous System Markers Revenue by Application (2017-2028)
10.3 Middle East and Africa Nervous System Markers Market Size by Country
10.3.1 Middle East and Africa Nervous System Markers Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nervous System Markers Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Athena Diagnostics
11.1.1 Athena Diagnostics Corporation Information
11.1.2 Athena Diagnostics Overview
11.1.3 Athena Diagnostics Nervous System Markers Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Athena Diagnostics Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Athena Diagnostics Recent Developments
11.2 Myriad RBM
11.2.1 Myriad RBM Corporation Information
11.2.2 Myriad RBM Overview
11.2.3 Myriad RBM Nervous System Markers Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Myriad RBM Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Myriad RBM Recent Developments
11.3 AbaStar MDx
11.3.1 AbaStar MDx Corporation Information
11.3.2 AbaStar MDx Overview
11.3.3 AbaStar MDx Nervous System Markers Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 AbaStar MDx Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 AbaStar MDx Recent Developments
11.4 QIAGEN
11.4.1 QIAGEN Corporation Information
11.4.2 QIAGEN Overview
11.4.3 QIAGEN Nervous System Markers Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 QIAGEN Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 QIAGEN Recent Developments
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Corporation Information
11.5.2 Thermo Fisher Scientific Overview
11.5.3 Thermo Fisher Scientific Nervous System Markers Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Thermo Fisher Scientific Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Thermo Fisher Scientific Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nervous System Markers Industry Chain Analysis
12.2 Nervous System Markers Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nervous System Markers Production Mode & Process
12.4 Nervous System Markers Sales and Marketing
12.4.1 Nervous System Markers Sales Channels
12.4.2 Nervous System Markers Distributors
12.5 Nervous System Markers Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nervous System Markers Industry Trends
13.2 Nervous System Markers Market Drivers
13.3 Nervous System Markers Market Challenges
13.4 Nervous System Markers Market Restraints
14 Key Findings in The Global Nervous System Markers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Nervous System Markers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Imaging Biomarkers
Table 3. Major Manufacturers of Metabolomics Biomarkers
Table 4. Major Manufacturers of Proteomic Biomarkers
Table 5. Major Manufacturers of Genomics Biomarkers
Table 6. Global Nervous System Markers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Nervous System Markers Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Nervous System Markers Sales by Region (2017-2022) & (K Units)
Table 9. Global Nervous System Markers Sales Market Share by Region (2017-2022)
Table 10. Global Nervous System Markers Sales by Region (2023-2028) & (K Units)
Table 11. Global Nervous System Markers Sales Market Share by Region (2023-2028)
Table 12. Global Nervous System Markers Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Nervous System Markers Revenue Market Share by Region (2017-2022)
Table 14. Global Nervous System Markers Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Nervous System Markers Revenue Market Share by Region (2023-2028)
Table 16. Global Nervous System Markers Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Nervous System Markers Sales Share by Manufacturers (2017-2022)
Table 18. Global Nervous System Markers Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Nervous System Markers Revenue Share by Manufacturers (2017-2022)
Table 20. Nervous System Markers Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Nervous System Markers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Nervous System Markers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nervous System Markers as of 2021)
Table 23. Nervous System Markers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Nervous System Markers Product Offered
Table 25. Date of Manufacturers Enter into Nervous System Markers Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nervous System Markers Sales by Type (2017-2022) & (K Units)
Table 28. Global Nervous System Markers Sales by Type (2023-2028) & (K Units)
Table 29. Global Nervous System Markers Sales Share by Type (2017-2022)
Table 30. Global Nervous System Markers Sales Share by Type (2023-2028)
Table 31. Global Nervous System Markers Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Nervous System Markers Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Nervous System Markers Revenue Share by Type (2017-2022)
Table 34. Global Nervous System Markers Revenue Share by Type (2023-2028)
Table 35. Nervous System Markers Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Nervous System Markers Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Nervous System Markers Sales by Application (2017-2022) & (K Units)
Table 38. Global Nervous System Markers Sales by Application (2023-2028) & (K Units)
Table 39. Global Nervous System Markers Sales Share by Application (2017-2022)
Table 40. Global Nervous System Markers Sales Share by Application (2023-2028)
Table 41. Global Nervous System Markers Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Nervous System Markers Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Nervous System Markers Revenue Share by Application (2017-2022)
Table 44. Global Nervous System Markers Revenue Share by Application (2023-2028)
Table 45. Nervous System Markers Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Nervous System Markers Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Nervous System Markers Sales by Type (2017-2022) & (K Units)
Table 48. North America Nervous System Markers Sales by Type (2023-2028) & (K Units)
Table 49. North America Nervous System Markers Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Nervous System Markers Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Nervous System Markers Sales by Application (2017-2022) & (K Units)
Table 52. North America Nervous System Markers Sales by Application (2023-2028) & (K Units)
Table 53. North America Nervous System Markers Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Nervous System Markers Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Nervous System Markers Sales by Country (2017-2022) & (K Units)
Table 56. North America Nervous System Markers Sales by Country (2023-2028) & (K Units)
Table 57. North America Nervous System Markers Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Nervous System Markers Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Nervous System Markers Sales by Type (2017-2022) & (K Units)
Table 60. Europe Nervous System Markers Sales by Type (2023-2028) & (K Units)
Table 61. Europe Nervous System Markers Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Nervous System Markers Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Nervous System Markers Sales by Application (2017-2022) & (K Units)
Table 64. Europe Nervous System Markers Sales by Application (2023-2028) & (K Units)
Table 65. Europe Nervous System Markers Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Nervous System Markers Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Nervous System Markers Sales by Country (2017-2022) & (K Units)
Table 68. Europe Nervous System Markers Sales by Country (2023-2028) & (K Units)
Table 69. Europe Nervous System Markers Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Nervous System Markers Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Nervous System Markers Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Nervous System Markers Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Nervous System Markers Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Nervous System Markers Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Nervous System Markers Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Nervous System Markers Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Nervous System Markers Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Nervous System Markers Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Nervous System Markers Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Nervous System Markers Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Nervous System Markers Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Nervous System Markers Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Nervous System Markers Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Nervous System Markers Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Nervous System Markers Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Nervous System Markers Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Nervous System Markers Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Nervous System Markers Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Nervous System Markers Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Nervous System Markers Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Nervous System Markers Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Nervous System Markers Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Nervous System Markers Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Nervous System Markers Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Nervous System Markers Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Nervous System Markers Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Nervous System Markers Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Nervous System Markers Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Nervous System Markers Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Nervous System Markers Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Nervous System Markers Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Nervous System Markers Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Nervous System Markers Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Nervous System Markers Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Nervous System Markers Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Nervous System Markers Revenue by Country (2023-2028) & (US$ Million)
Table 107. Athena Diagnostics Corporation Information
Table 108. Athena Diagnostics Description and Major Businesses
Table 109. Athena Diagnostics Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Athena Diagnostics Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Athena Diagnostics Recent Developments
Table 112. Myriad RBM Corporation Information
Table 113. Myriad RBM Description and Major Businesses
Table 114. Myriad RBM Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Myriad RBM Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Myriad RBM Recent Developments
Table 117. AbaStar MDx Corporation Information
Table 118. AbaStar MDx Description and Major Businesses
Table 119. AbaStar MDx Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. AbaStar MDx Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. AbaStar MDx Recent Developments
Table 122. QIAGEN Corporation Information
Table 123. QIAGEN Description and Major Businesses
Table 124. QIAGEN Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. QIAGEN Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. QIAGEN Recent Developments
Table 127. Thermo Fisher Scientific Corporation Information
Table 128. Thermo Fisher Scientific Description and Major Businesses
Table 129. Thermo Fisher Scientific Nervous System Markers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Thermo Fisher Scientific Nervous System Markers Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Thermo Fisher Scientific Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Nervous System Markers Distributors List
Table 135. Nervous System Markers Customers List
Table 136. Nervous System Markers Market Trends
Table 137. Nervous System Markers Market Drivers
Table 138. Nervous System Markers Market Challenges
Table 139. Nervous System Markers Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Nervous System Markers Product Picture
Figure 3. Global Nervous System Markers Market Share by Type in 2021 & 2028
Figure 3. Imaging Biomarkers Product Picture
Figure 4. Metabolomics Biomarkers Product Picture
Figure 5. Proteomic Biomarkers Product Picture
Figure 6. Genomics Biomarkers Product Picture
Figure 7. Global Nervous System Markers Market Share by Application in 2021 & 2028
Figure 8. Spinal Muscular Atrophy (SMA)
Figure 9. Multiple Sclerosis
Figure 10. Depression
Figure 11. Schizophrenia
Figure 12. Huntington's Disease
Figure 13. Parkinson's Disease
Figure 14. Alzheimer's Disease
Figure 15. Nervous System Markers Report Years Considered
Figure 16. Global Nervous System Markers Sales 2017-2028 (K Units)
Figure 17. Global Nervous System Markers Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Nervous System Markers Revenue 2017-2028 (US$ Million)
Figure 19. Global Nervous System Markers Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Nervous System Markers Sales Market Share by Region (2017-2022)
Figure 21. Global Nervous System Markers Sales Market Share by Region (2023-2028)
Figure 22. North America Nervous System Markers Sales YoY (2017-2028) & (K Units)
Figure 23. North America Nervous System Markers Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Nervous System Markers Sales YoY (2017-2028) & (K Units)
Figure 25. Europe Nervous System Markers Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Nervous System Markers Sales YoY (2017-2028) & (K Units)
Figure 27. Asia-Pacific Nervous System Markers Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Nervous System Markers Sales YoY (2017-2028) & (K Units)
Figure 29. Latin America Nervous System Markers Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Nervous System Markers Sales YoY (2017-2028) & (K Units)
Figure 31. Middle East & Africa Nervous System Markers Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Nervous System Markers Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Nervous System Markers in the World: Market Share by Nervous System Markers Revenue in 2021
Figure 34. Global Nervous System Markers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Nervous System Markers Sales Market Share by Type (2017-2028)
Figure 36. Global Nervous System Markers Revenue Market Share by Type (2017-2028)
Figure 37. Global Nervous System Markers Sales Market Share by Application (2017-2028)
Figure 38. Global Nervous System Markers Revenue Market Share by Application (2017-2028)
Figure 39. North America Nervous System Markers Sales Market Share by Type (2017-2028)
Figure 40. North America Nervous System Markers Revenue Market Share by Type (2017-2028)
Figure 41. North America Nervous System Markers Sales Market Share by Application (2017-2028)
Figure 42. North America Nervous System Markers Revenue Market Share by Application (2017-2028)
Figure 43. North America Nervous System Markers Sales Share by Country (2017-2028)
Figure 44. North America Nervous System Markers Revenue Share by Country (2017-2028)
Figure 45. United States Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Nervous System Markers Sales Market Share by Type (2017-2028)
Figure 48. Europe Nervous System Markers Revenue Market Share by Type (2017-2028)
Figure 49. Europe Nervous System Markers Sales Market Share by Application (2017-2028)
Figure 50. Europe Nervous System Markers Revenue Market Share by Application (2017-2028)
Figure 51. Europe Nervous System Markers Sales Share by Country (2017-2028)
Figure 52. Europe Nervous System Markers Revenue Share by Country (2017-2028)
Figure 53. Germany Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 54. France Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Nervous System Markers Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Nervous System Markers Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Nervous System Markers Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Nervous System Markers Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Nervous System Markers Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Nervous System Markers Revenue Share by Region (2017-2028)
Figure 64. China Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 67. India Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 69. China Taiwan Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Nervous System Markers Sales Market Share by Type (2017-2028)
Figure 74. Latin America Nervous System Markers Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Nervous System Markers Sales Market Share by Application (2017-2028)
Figure 76. Latin America Nervous System Markers Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Nervous System Markers Sales Share by Country (2017-2028)
Figure 78. Latin America Nervous System Markers Revenue Share by Country (2017-2028)
Figure 79. Mexico Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 82. Colombia Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Nervous System Markers Sales Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Nervous System Markers Revenue Market Share by Type (2017-2028)
Figure 85. Middle East and Africa Nervous System Markers Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Nervous System Markers Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Nervous System Markers Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Nervous System Markers Revenue Share by Country (2017-2028)
Figure 89. Turkey Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Nervous System Markers Revenue (2017-2028) & (US$ Million)
Figure 92. Nervous System Markers Value Chain
Figure 93. Nervous System Markers Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed

以下、関連資料のご紹介

中枢神経系（CNS）治療のグローバル市場インサイト・予測（～2028年）

Global Central Nervous System Therapy Market Insights, Forecast to 2028
QY2207C3852 2022年7月11日 106Pages
新型コロナウイルス感染症のパンデミックにより、世界の中枢神経系（CNS）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に中枢神経系（...

ニューロンマーカーのグローバル市場インサイト・予測（～2028年）

Global Neuronal Markers Market Insights, Forecast to 2028
QY2207E09880 2022年7月 97Pages
新型コロナウイルス感染症のパンデミックにより、世界のニューロンマーカーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にニューロンマーカー...

油性マーカーのグローバル市場インサイト・予測（～2028年）

Global Permanent Markers Market Insights, Forecast to 2028
QY2207E03687 2022年7月 105Pages
新型コロナウイルス感染症のパンデミックにより、世界の油性マーカーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に油性マーカーの世界市場の...

ケーブル＆ワイヤーマーカーのグローバル市場インサイト・予測（～2028年）

Global Cable and Wire Markers Market Insights, Forecast to 2028
QY2207C1378 2022年7月8日 117Pages
新型コロナウイルス感染症のパンデミックにより、世界のケーブル＆ワイヤーマーカーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にケーブル＆...

3Dファイバーレーザーマーカーのグローバル市場インサイト・予測（～2028年）

Global 3D Fiber Laser Markers Market Insights, Forecast to 2028
QY2207E05829 2022年7月 107Pages
新型コロナウイルス感染症のパンデミックにより、世界の3Dファイバーレーザーマーカーの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に3Dフ...

ニューロンマーカーのグローバル市場インサイト・予測（～2028年） A major percentage of world population is affected by neurological disorders, this in turn is causing major disabilities globally. Due to the high incidence of neurological disorders, there is the need for biomarkers as biomarkers measure biological states and are used for indication of both pathoge…
薬力（PD）バイオマーカーのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Pharmacodynamic (PD) Biomarkers Market The global Pharmacodynamic (PD) Biomarkers market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028. Fully considering the economic change by this health crisis, Exposu…
中枢神経系（CNS）治療のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Central Nervous System Therapy Market Due to the COVID-19 pandemic, the global Central Nervous System Therapy market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast…
世界のPARP阻害剤バイオマーカー試験製品市場予測（～2028年）：検査キット、検査アッセイ The PARP Inhibitor Biomarkers Testing Product market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
乳がんバイオマーカーのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Breast Cancer Biomarkers Market Due to the COVID-19 pandemic, the global Breast Cancer Biomarkers market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022…